Results 181 to 190 of about 59,410 (289)
Update on new autoinflammatory disorders from the 2024 Pediatric Rheumatology European Society Congress. [PDF]
Schulert GS.
europepmc +1 more source
Dermatologic Findings of RELA‐Associated Autoinflammatory Disease
ABSTRACT Variants in the gene RELA have been implicated in a monogenic, hereditary form of Behcet's‐like syndrome. This case series describes the dermatologic manifestations of three patients with identified RELA‐associated autoinflammatory disease.
Elizabeth Nourse +4 more
wiley +1 more source
Editorial: Building a learning health system in pediatric rheumatology. [PDF]
Morgan EM +3 more
europepmc +1 more source
2.19. Pediatric rheumatology [PDF]
openaire +1 more source
ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung +5 more
wiley +1 more source
ABSTRACT A 16‐year‐old girl presenting with calcinosis cutis and localized scleroderma subsequently developed delayed‐onset idiopathic inflammatory myopathy five years after initial skin involvement. Despite the absence of typical dermatomyositis features and negative myositis‐specific antibodies, whole‐body MRI revealed extensive subclinical muscle ...
Edoardo Marrani +5 more
wiley +1 more source
Editorial: Promoting patient-centered care for pediatric rheumatology across Africa. [PDF]
Hamdi W, Migowa A.
europepmc +1 more source
Enhanced PIEZO1 expression in mast cells of mastocytosis skin lesions: Relevance to Darier's sign
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Yoshiaki Kobayashi +9 more
wiley +1 more source
Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn +14 more
wiley +1 more source

